Stockscreener 앱 받기
15.70
2.61%
-0.42
시간 외 거래:
15.55
-0.15
-0.96%
전일 마감가:
$16.12
열려 있는:
$16.14
하루 거래량:
447.65K
Relative Volume:
1.08
시가총액:
$637.66M
수익:
-
순이익/손실:
$-168.05M
주가수익비율:
-3.0604
EPS:
-5.13
순현금흐름:
$-146.15M
1주 성능:
-1.51%
1개월 성능:
+0.32%
6개월 성능:
+28.27%
1년 성능:
-72.83%
1일 변동 폭
$15.68
$16.18
1주일 범위
$15.50
$16.57
52주 변동 폭
$9.12
$72.37
Keros Therapeutics Inc Stock (KROS) Company Profile
명칭
Keros Therapeutics Inc
전화
617-314-6297
주소
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA
KROS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KROS
Keros Therapeutics Inc
|
15.70 | 654.72M | 0 | -168.05M | -146.15M | -5.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Keros Therapeutics Inc Stock (KROS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-10 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-01-21 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-01-17 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2024-12-16 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-12-16 | 재확인 | Oppenheimer | Outperform |
| 2024-12-13 | 재확인 | H.C. Wainwright | Buy |
| 2024-12-12 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-12-12 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-12-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-11-05 | 개시 | Jefferies | Buy |
| 2024-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-09-23 | 개시 | Guggenheim | Buy |
| 2024-06-25 | 개시 | Oppenheimer | Outperform |
| 2024-02-21 | 개시 | William Blair | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2023-07-31 | 개시 | Wedbush | Outperform |
| 2023-07-26 | 개시 | BofA Securities | Buy |
| 2023-02-14 | 개시 | Cowen | Outperform |
| 2022-10-18 | 개시 | Truist | Buy |
| 2022-07-26 | 개시 | BTIG Research | Buy |
| 2020-12-08 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-04 | 개시 | H.C. Wainwright | Buy |
| 2020-05-04 | 개시 | Jefferies | Buy |
| 2020-05-04 | 개시 | Piper Sandler | Overweight |
| 2020-05-04 | 개시 | SVB Leerink | Outperform |
모두보기
Keros Therapeutics Inc 주식(KROS)의 최신 뉴스
Keros Therapeutics Inc. stock daily chart insightsMarket Volume Summary & Long Hold Capital Preservation Tips - newser.com
Published on: 2025-10-10 05:54:47 - newser.com
Weiss Ratings Reaffirms "Sell (D)" Rating for Keros Therapeutics (NASDAQ:KROS) - MarketBeat
Investors in Keros Therapeutics (NASDAQ:KROS) have unfortunately lost 72% over the last year - Yahoo Finance
Can machine learning forecast Keros Therapeutics Inc. recoveryPortfolio Value Summary & Expert Verified Movement Alerts - newser.com
What analysts say about Keros Therapeutics Inc stockInsider Trading Compliance & Learn What Analysts Rate “Strong Buy” - earlytimes.in
Public Employees Retirement System of Ohio Purchases Shares of 26,103 Keros Therapeutics, Inc. $KROS - MarketBeat
Can Keros Therapeutics Inc. recover in the next quarterMarket Performance Recap & Growth Oriented Trading Recommendations - newser.com
Can Keros Therapeutics Inc. rally from current levelsGap Down & Weekly Market Pulse Alerts - newser.com
Will Keros Therapeutics Inc. bounce back from current supportQuarterly Earnings Report & Long-Term Capital Growth Strategies - newser.com
How to interpret RSI for Keros Therapeutics Inc. stockWeekly Stock Summary & Proven Capital Preservation Methods - newser.com
Quantitative breakdown of Keros Therapeutics Inc. recent moveTake Profit & Risk Controlled Stock Pick Alerts - newser.com
Is Keros Therapeutics Inc. stock poised for growthTrade Analysis Report & Growth Oriented Trade Recommendations - newser.com
What momentum indicators show for Keros Therapeutics Inc. stockWeekly Risk Report & Verified Entry Point Signals - newser.com
Keros Therapeutics Inc Stock Analysis and ForecastHigh Yield Income Stocks & Low Entry Cost Investment - earlytimes.in
Is Peeti Securities Limited Positioned to Benefit From Geographic ExpansionSector Performance Review & Achieve Triple Digit Returns - earlytimes.in
Is Keros Therapeutics Inc a good long term investmentEconomic Indicators Overview & Affordable Market Investment - earlytimes.in
What drives Keros Therapeutics Inc stock priceContrarian Investment Ideas & Today’s Picks, Tomorrow’s Winners - earlytimes.in
Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the American Society of Bone and Mineral Research 2025 Annual Meeting - ADVFN
Keros Therapeutics Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Assenagon Asset Management S.A. Purchases 36,360 Shares of Keros Therapeutics, Inc. $KROS - MarketBeat
Keros Therapeutics: A Potential Dart Throw (NASDAQ:KROS) - Seeking Alpha
TGF-β Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Keros Therapeutics, Inc. (NASDAQ:KROS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Is now a turning point for Keros Therapeutics Inc.Watch List & Reliable Price Breakout Alerts - newser.com
CEO Change: Whats next for National Storage Affiliates Trust stockMarket Trend Report & Weekly High Potential Stock Alerts - خودرو بانک
Layoff Watch: Is Liberty Global Ltd stock risky to hold now2025 Investor Takeaways & Entry and Exit Point Strategies - خودرو بانک
Acadian Asset Management LLC Invests $1.50 Million in Keros Therapeutics, Inc. $KROS - MarketBeat
Goldman Sachs Group Inc. Buys 205,022 Shares of Keros Therapeutics, Inc. $KROS - MarketBeat
Keros Therapeutics Inc (KROS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Keros Therapeutics Inc 주식 (KROS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 10% Owner |
Apr 09 '25 |
Buy |
10.13 |
934,258 |
9,464,512 |
4,392,737 |
| Seehra Jasbir | CHIEF EXECUTIVE OFFICER |
Apr 04 '25 |
Option Exercise |
0.30 |
49,367 |
14,810 |
302,223 |
5.74%
자본화:
|
볼륨(24시간):